Why the study?
Does a 3-week perioperative pulmonary rehabilitation program improve pulmonary function differently in patients with COPD compared to those without COPD following CABG surgery?
Does a 3-week perioperative pulmonary rehabilitation program improve pulmonary function differently in patients with COPD compared to those without COPD following CABG surgery?
A 3-week perioperative pulmonary rehabilitation program improves respiratory muscle strength and lung function after CABG, with significantly greater improvements in expiratory flow measures seen in patients with comorbid COPD.
Purpose: It is unclear whether the effectiveness of pulmonary rehabilitation program (PRP) after cardiac surgery differs between patients with and without COPD. This study aimed to compare the effectiveness of PRP between patients with and without COPD undergoing coronary artery bypass graft (CABG) surgery. Patients and methods: We retrospectively included patients who underwent CABG surgery and received 3-week PRP from January 2009 to December 2013. We excluded patients who underwent emergency surgery, had an unstable hemodynamic status, were ventilator dependent or did not complete the PRP. Demographics, muscle strength, degree of dyspnea, pulmonary function and postoperative complications were compared. Results: Seventy-eight patients were enrolled (COPD group, n=40; non-COPD group, n=38). Maximal inspiratory pressure (MIP; −34.52 cmH 2 O vs −43.25 cmH 2 O, P <0.01; −34.67 cmH 2 O vs −48.18 cmH 2 O, P <0.01), maximal expiratory pressure (MEP; 32.15 cmH 2 O vs 46.05 cmH 2 O, P <0.01; 37.78 cmH 2 O vs 45.72 cmH 2 O, P <0.01) and respiratory rate (RR; 20.65 breath/minute vs 17.02 breath/minute, P <0.01; 20.65 breath/minute vs 17.34 breath/minute, P <0.01) in COPD and non-COPD groups, respectively, showed significant improvement, but were not significantly different between the two groups. Forced vital capacity (FVC; 0.85 L vs 1.25 L, P <0.01), forced expiratory volume in 1 second (FEV 1 ; 0.75 L vs 1.08 L, P <0.01), peak expiratory flow (PEF; 0.99 L vs 1.79 L, P <0.01) and forced expiratory flow between 25% and 75% of vital capacity (FEF 25–75 ; 0.68 L vs 1.15 L, P <0.01) showed significant improvement between postoperative Days 1 and 14 in the COPD group. FVC (1.11 L vs 1.36 L, P <0.05), FEV 1 (96 L vs 1.09 L, P <0.05) and FEF 25–75 (1.03 L vs 1.26 L, P <0.05) were significantly improved in the non-COPD group. However, only PEF (80.8% vs 10.1%, P <0.01) and FEF 25–75 (67.6% vs 22.3%, P <0.05) were more significantly improved in the COPD group than in the non-COPD group. Conclusion: PRP significantly improved respiratory muscle strength and lung function in patients with and without COPD who underwent CABG surgery. However, PRP is more effective in improving PEF and FEF 25–75 in COPD patients.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: